Clinical Trial

Molecular Citology to Detect Free Cancer Cells in Peritoneal Fluid

Study acronym: OSNA
Completed
View on ClinicalTrials.gov →
Summary
In gastrointestinal malignancies peritoneal diffusion represent a severe adverse event. Current methodoly including cytology of peritoneal fluid appears insufficient. It's crucial to individuate new technology.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-03-12.
Trial Details
NCT Number NCT07478107
Lead Sponsor University of Campania Luigi Vanvitelli
Conditions Peritoneal Carcinomatosis
Enrollment 108 participants
Start Date 2024-07-01
Primary Completion 2025-10-31 (estimated)
Study Completion 2026-02-28 (estimated)
Updated on ClinicalTrials.gov 2026-03-20